The investment seeks to provide long-term growth of capital primarily through investment in equity securities; current income is a secondary objective... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeValue
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EFAD | 41.35 | 0.16 | +0.39% |
ProShares MSCI EAFE Dividend Growers | |||
PMAY | 36.18 | 0.05 | +0.12% |
Innovator U.S. Equity Power BffrETF™-May | |||
SPHD | 47.35 | -0.02 | -0.04% |
Invesco S&P 500® High Div Low Vol ETF | |||
FLRG | 33.45 | -0.06 | -0.18% |
Fidelity U.S. Multifactor ETF | |||
HELX | 25.66 | -0.47 | -1.81% |
Franklin Genomic Advancements ETF |
A.I.dvisor indicates that over the last year, JDVFX has been closely correlated with RMFEX. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if JDVFX jumps, then RMFEX could also see price increases.
Ticker / NAME | Correlation To JDVFX | 1D Price Change % | ||
---|---|---|---|---|
JDVFX | 100% | +0.18% | ||
RMFEX - JDVFX | 80% Closely correlated | -0.22% | ||
VIVAX - JDVFX | 79% Closely correlated | -0.11% | ||
VIVIX - JDVFX | 79% Closely correlated | -0.11% | ||
RMEBX - JDVFX | 79% Closely correlated | -0.22% | ||
RMFCX - JDVFX | 79% Closely correlated | -0.22% | ||
More |